A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
BIOGEN INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 24, 2024
by SEC Edgar Filings
|
European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC
Published:
April 22, 2024
by Janssen Pharmaceutical Companies
|
Taiwan Patent Office Publishes Univ Chiba Nat Univ Corp and Kikkoman Corp's Patent Application for COVID 19 Therapeutic or Prophylactic Drug Comprising Selenoneine
Published:
April 20, 2024
by Pharmaceutical Patent News
|
Patent Issued for Protein solution formulation containing high concentration of an anti-VEGF antibody (USPTO 11945859)
Published:
April 19, 2024
by Angiogenesis Daily
|
RI S2946: Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Published:
April 19, 2024
by Rhode Island 2024 Regular Session
|
Ask us about our Consumer Wellness market view